University of Missouri researchers uncover the antiviral potential of defensins — tiny proteins with big possibilities in ...

Discover what glycan analysis can reveal about protein behavior and how it can be used to boost biologic performance and ...

Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...

The H5N1 avian flu is circulating in cows and other mammals. Whether it will make a permanent leap to humans is another ...

At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...

H5N1 avian influenza has long been a concerning virus. Since its discovery in 1996 in waterfowl, bird flu has occasionally ...

Otsuka Pharmaceutical has signed an agreement to acquire all assets related to Cantargia's early-clinical stage CAN10 ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...

The discovery of a ligand peptide that could serve as a targeted molecular imaging agent for human tissue injury may ...

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in ...